Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,984
41 years, by papers

Newest first

2,251 to 2,300 of 3,984

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial.

    Diabetes, obesity & metabolism2017PMID 27935183

  • Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial.

    Diabetes care2017PMID 27998910Indexed under metformin in PubMed's chemical list

  • Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.

    Diabetes care2017PMID 27999002Indexed under metformin in PubMed's chemical list

  • Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study).

    Diabetes, obesity & metabolism2017PMID 28026912

  • Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.

    International journal of epidemiology2017PMID 28031313

  • A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose alone.

    Current medical research and opinion2017PMID 28035868Indexed under metformin in PubMed

  • A pilot study of D-chiro-inositol plus folic acid in overweight patients with type 1 diabetes.

    Acta diabetologica2017PMID 28039583Indexed under metformin in PubMed's chemical list

  • Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.

    Annals of internal medicine2017PMID 28055049

  • Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension.

    Diabetes, obesity & metabolism2017PMID 28058750

  • Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.

    Current medical research and opinion2017PMID 28058854

  • Metformin prevents metabolic side effects during systemic glucocorticoid treatment.

    European journal of endocrinology2017PMID 28073907

  • Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial.

    Diabetes, obesity & metabolism2017PMID 28075066

  • Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study.

    Diabetes care2017PMID 28077460

  • Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naïve Asian patients with type 2 diabetes.

    Diabetes research and clinical practice2017PMID 28088030

  • Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study.

    Clinical endocrinology2017PMID 28092404

  • Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study.

    Diabetes care2017PMID 28096223

  • Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction.

    Circulation. Cardiovascular genetics2017PMID 28100626

  • Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.

    Oncotarget2017PMID 28103573

  • Causal Effects of Intensive Lifestyle and Metformin Interventions on Cardiovascular Disease Risk Factors in Pre-Diabetic People: An Application of G-Estimation.

    Archives of Iranian medicine2017PMID 28112533

  • Effects of Type 2 Diabetes Mellitus in Patients on Treatment With Glibenclamide and Metformin on Carvedilol Enantiomers Metabolism.

    Journal of clinical pharmacology2017PMID 28114735

  • Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome.

    The Cochrane database of systematic reviews2017PMID 28118681

  • Liraglutide causes large and rapid epicardial fat reduction.

    Obesity (Silver Spring, Md.)2017PMID 28124506Indexed under metformin in PubMed's chemical list

  • Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.

    Diabetes, obesity & metabolism2017PMID 28124822Indexed under metformin in PubMed's chemical list

  • Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.

    Journal of hypertension2017PMID 28129251Indexed under metformin in PubMed's chemical list

  • Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial.

    BMC endocrine disorders2017PMID 28143456

  • The effect of adding metformin to insulin therapy for type 1 diabetes mellitus children: A systematic review and meta-analysis.

    Pediatric diabetes2017PMID 28145083

  • Impact of DPP-4 inhibition on acute and chronic endothelial function in humans with type 2 diabetes on background metformin therapy.

    Vascular medicine (London, England)2017PMID 28145158

  • The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome.

    Hormone molecular biology and clinical investigation2017PMID 28157691

  • Long-term Metformin Therapy and Monitoring for Vitamin B12 Deficiency Among Older Veterans.

    Journal of the American Geriatrics Society2017PMID 28182265Indexed under metformin in PubMed's chemical list; tests metformin

  • Efficacy and safety of autoinjected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical study.

    Diabetes, obesity & metabolism2017PMID 28205322

  • Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control.

    Archives of endocrinology and metabolism2017PMID 28225996

  • Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.

    Fertility and sterility2017PMID 28228317

  • PREVENT-DM Comparative Effectiveness Trial of Lifestyle Intervention and Metformin.

    American journal of preventive medicine2017PMID 28237635

  • Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12-week trial.

    Diabetes, obesity & metabolism2017PMID 28239939

  • Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.

    Journal of diabetes research2017PMID 28271076

  • Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial.

    Science China. Life sciences2017PMID 28271251

  • The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.

    International urology and nephrology2017PMID 28271326

  • Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study).

    Diabetes, obesity & metabolism2017PMID 28296055

  • Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved β-cell function and insulin sensitivity in metformin treated PCOS.

    Endocrine research2017PMID 28323503

  • Evaluating the costs of glycemic response with canagliflozin versus dapagliflozin and empagliflozin as add-on to metformin in patients with type 2 diabetes mellitus in the United Arab Emirates.

    Current medical research and opinion2017PMID 28323512

  • Caloric Restriction Mimetics Slow Aging of Neuromuscular Synapses and Muscle Fibers.

    The journals of gerontology2017PMID 28329051Indexed under metformin in PubMed's chemical list

  • Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease.

    Journal of diabetes2017PMID 28332301

  • Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial.

    The lancet. Diabetes & endocrinology2017PMID 28344112Indexed under metformin in PubMed's chemical list

  • Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials.

    Journal of psychopharmacology (Oxford, England)2017PMID 28372526

  • Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.

    Journal of clinical oncology2017PMID 28375706

  • Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.

    The lancet. Diabetes & endocrinology2017PMID 28385659Indexed under metformin in PubMed's chemical list

  • Ergogenic properties of metformin in simulated high altitude.

    Clinical and experimental pharmacology & physiology2017PMID 28394459

  • Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.

    Cardiovascular diabetology2017PMID 28403850Indexed under metformin in PubMed's chemical list

  • Impact of metformin on C-reactive protein levels in women with polycystic ovary syndrome: a meta-analysis.

    Oncotarget2017PMID 28404960

  • Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg .

    International journal of clinical pharmacology and therapeutics2017PMID 28406090

The next 50 papers

← Previous 50